Revenue
2020
2021
2022
2023
2024
2025
Iconic Labs Plc (ICON)
Price—Loading quote
Net income
2020
2021
2022
2023
2024
2025
Free cash flow
2020
2021
Total cash / debt
CashTotal debt
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Revenue | £0 | £0 | £0 | £26,823 | £509,171 | £107,303 |
| Gross profit | £0 | £0 | £0 | £26,823 | £509,171 | £107,303 |
| Gross margin | — | — | — | 100.00% | 100.00% | 100.00% |
| Operating expenses | £555,119 | £246,052 | £1.6M | £788,930 | £3.6M | £2.6M |
| Operating income | −£555,119 | −£246,052 | £4.6M | −£762,107 | −£3.1M | −£2.5M |
| Operating margin | — | — | — | −2,841.24% | −608.93% | −2,317.79% |
| EBITDA | −£555,119 | −£246,052 | −£1.6M | −£307,356 | — | — |
| EBITDA margin | — | — | — | −1,145.87% | — | — |
| Net income | −£628,225 | −£246,052 | £4.6M | −£762,107 | −£7.7M | −£2.4M |
| Net profit margin | — | — | — | −2,841.24% | −1,511.73% | −2,227.45% |
| Basic EPSper basic share | -£0.06 | -£0.03 | £0.98 | £0.00 | £0.00 | — |
| Diluted EPSper diluted share | -£0.06 | -£0.03 | £0.17 | £0.00 | £0.00 | — |